During the past decade, Fakultni nemocnice Olomouc, Neurologicka klinika conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultni nemocnice Olomouc, Neurologicka klinika" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 1 trials, followed by "Eisai Inc." with 1 trials sponsored, "European Huntington's Disease Network" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Revance Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni nemocnice Olomouc, Neurologicka klinika" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice Olomouc, Neurologicka klinika" are "Cervical Dystonia" (1 trials), "Huntington Disease" (1 trials), "Huntington's Disease" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Fakultni nemocnice Olomouc, Neurologicka klinika" in a lesser frequency.

Most popular intervention types in "Fakultni nemocnice Olomouc, Neurologicka klinika" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Data Collection" (1 trials), "DaxibotulinumtoxinA for injection" (1 trials), "Everolimus" (1 trials), "Lenvatinib" (1 trials) and "Ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni nemocnice Olomouc, Neurologicka klinika" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Fakultni nemocnice Olomouc, Neurologicka klinika". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fakultni nemocnice Olomouc, Neurologicka klinika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni nemocnice Olomouc, Neurologicka klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".